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Objective To determine the relationships between parity, obstetric adversities, neonatal factors, and Tourette
syndrome in a large nationwide cohort.
Study design This nationwide, register-based, nested case-control study identified all children diagnosed with
Tourette syndrome born between 1991 and 2010 from the Finnish Hospital Discharge Register (n = 767). Each
case was matched to 4 controls. Information on parity, obstetric, and neonatal factors was obtained from the
Finnish Medical Birth Register. Conditional logistic regression was used to determine the relationship between par-
ity, obstetric, and neonatal factors, and Tourette syndrome.
Results Nulliparity was associated with increased odds for Tourette syndrome (OR 1.7, 95% CI 1.4-2.2), and 3 or
more previous births was associated with decreased odds for Tourette syndrome (OR 0.5, 95% CI 0.3-0.9)
compared with parity 1-2. Birth weight 4000-4499 g was associated with decreased odds for Tourette syndrome
(OR 0.7, 95% CI 0.5-0.9). Low birth weight, gestational age, weight for gestational age, Apgar score at 1 minute,
induced labor, birth type or presentation, neonatal treatment, or maternal blood pressure were not associated
with Tourette syndrome.
Conclusions Increasing parity and high birth weight are associated with decreased odds for Tourette syndrome.
(J Pediatr 2016;171:213-9).See editorial, p 17ourette syndrome is a childhood onset neurodevelopmental disorder characterized by multiple motor and 1 or moreTvocal tics that have been present for more than a year.1 The complex etiology of Tourette syndrome is likely to involvemultifactorial genetic and environmental influences,2-4 although underlying pathophysiological mechanisms and the
role of potential gene-environmental interactions are as yet unclear.
Both obstetric and neonatal factors have been associated with neurodevelopmental disorders, such as attention deficit hy-
peractivity disorder (ADHD) and autism spectrum disorder (ASD).5-11 A growing body of evidence suggests that parity, partic-
ularly being the first born, is associated with an increased risk of autism.12-14 Most previous studies on the association between
obstetric and neonatal factors and Tourette syndrome were retrospective in design and conducted on clinical samples.15-23 Low
birth weight,15,16 complications during pregnancy,17 and Apgar scores at 5 minutes18 have been reported to be associated with
Tourette syndrome16,18 or tic severity.15,17 These findings, however, have not been replicated or have been inconsistent.15,18-21
Two population-based studies have examined the association between perinatal factors and Tourette syndrome: one from Swe-
den23 and one derived from the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort.24 The Swedish study
included only 25 children with Tourette syndrome and examined the association between combined pre- and perinatal opti-
mality score and Tourette syndrome. No specific perinatal factors were evaluated.23 The ALSPAC birth cohort study included
50 children with Tourette syndrome; no associations were found between birth weight, prematurity, delivery complications,
Apgar score, or maternal blood pressure and Tourette syndrome.24 However, a negative, statistically significant (OR 0.7From the 1Department of Child Psychiatry, University of95% CI 0.5-0.97) association was found between parity (second or later born
vs first born) and Tourette syndrome/chronic tic disorder.24 Of note, Tourette
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ric and neonatal adversities are relatively uncommon. There-
fore, the low statistical power because of small sample sizes
used by these studies23,24 may have resulted in failure to
demonstrate subtle but important associations between ob-
stetric and neonatal factors and Tourette syndrome. A design
based on using national health register data overcomes many
limitations (eg, retrospectively collected data, small sample
sizes, geographically restricted area, and lack of healthcare
professional assessments) of the previous clinical and
population-based studies.
The present study is a nationwide register-based study
examining the relationships between several obstetric adver-
sities, perinatal factors, parity, and Tourette syndrome. The
aim of the study was to examine if birth weight, gestational
age, weight for gestational age, Apgar score at 1 minute,
induced labor, birth presentation, birth type, maternal blood
pressure, neonatal treatment, or parity are associated with
Tourette syndrome after adjusting for other parental back-
ground variables.
Methods
This nested case-control study used data derived from 3
Finnish national registries. The sampling frame included all
children born between January 1, 1991, and December 31,
2010, in Finland (n = 1 199 112). Children diagnosed with
Tourette syndrome (n = 767) during the same time period
were identified from the Finnish Hospital Discharge Register
(FHDR). The characteristics of the sample have been
described previously.26 Each case was matched to 4 controls,
identified from the Central Population Register, by sex, date
of birth, and place of birth. Personal identity codes were used
to link the data collected from the FHDR, the Finnish Med-
ical Birth Register (FMBR), and the Central Population Reg-
ister used in the study. The study was authorized by the
Ministry of Social Affairs and Health (STM/1528/2007) and
the National Institute of Health and Welfare with approval
from the ethics committee of the hospital district of South-
west Finland.
The FHDR contains all somatic and psychiatric diagnoses
given in hospitals in Finland, including inpatient wards, mil-
itary, health center, and prison wards, and private hospitals
from 1969 onward and public hospital outpatients from
1998 onward. Diagnoses are based on the International Clas-
sification of Diseases (ICD) (ICD Ninth Revision [ICD-9]
from 1987-1995 and ICD Tenth Revision [ICD-10] from
1996 onward). FHDR data have been shown to be of good
quality,27 and more specifically, Tourette syndrome diagno-
ses in the FHDR have been validated by chart reviews and
telephone interviews using the Yale Global Tic Severity
scale.26 The Central Population Register contains informa-
tion about Finnish citizens and foreign citizens residing
permanently in Finland, and includes name, personal iden-
tity code, address, citizenship, native language, family rela-
tions, and dates of emigration, immigration, birth, and
death. The FMBR, established in 1987 and maintained by214the National Institute of Health and Welfare, includes
detailed comprehensive data on maternal background, preg-
nancies, and the perinatal period up to 7 days of age.
Children with diagnosed Tourette syndrome (ICD-10:
F95.2, ICD-9: 3072D) without comorbid severe or profound
intellectual disability (ICD-10: F72, F73, ICD-9: 3181, 3182)
were identified from the FHDR (n = 767). Children born
from twin (n = 24) or triple (n = 1) pregnancies were
excluded. Data on perinatal factors were available for 738
of the remaining 742 children (99.5%). There were 207 Tour-
ette syndrome cases with comorbid hyperkinetic disorder,
120 cases with comorbid ASD, and 58 cases with comorbid
obsessive compulsive disorder.
The controls, defined as children without any tic disorder
or severe or profound intellectual disability, were identified
from the Central Population Register. Controls were
excluded if they had emigrated from Finland (n = 9), had
died before the case was diagnosed (n = 12), were born
from multiple pregnancies (n = 87), or if their case was
born from a multiple pregnancy (n = 98). The data on peri-
natal factors was available on 2810 of the remaining 2825
controls (99.5%).
Data on Exposures
Data on parity, obstetric, and neonatal factors were derived
from the FMBR. The studied obstetric and neonatal factors
were: (1) birth weight classified as <1500, 1500-2499, 2500-
3999, 4000-4499, and $4500 g; (2) gestational age classified
as <32, 32-37, 38-41, and $42 weeks; and (3) weight for
gestational age as small for gestational age (<2 SD), appro-
priate for gestational age (2 SD to 2 SD), and large for gesta-
tional age (>2 SD). Weight for gestational age was calculated
according to national sex-specific weight distribution stan-
dards at a given gestational age among children born between
1996 and 2008.28 Apgar scores at 1 minute were classified as
9-10, 7-8, and 0-6. Neonatal treatment was classified as either
normal follow-up or monitoring either in a maternal post-
partum department or a neonatal intensive care unit. Birth
presentation classified as cephalic, breech, or other. Birth
type was classified as vaginal cephalic, vacuum extractor or
forceps, or vaginal breech, planned cesarean, other cesarean
including urgent and emergency cesarean, and unknown.
Induced labor was classified as either yes or no. Maternal
high blood pressure that required hospitalization was either
yes or no. Parity was classified as 0, 1-2, and 3 or more pre-
vious births.
Covariates
Five parental factors that showed a trend of association
(P < .10 calculated using Pearson c2 test) with Tourette syn-
drome in this sample and at least one of the perinatal factors
in the literature29-34 were included in the analyses as covari-
ates. These covariates were maternal age (P = .003), maternal
psychiatric history (P < .001), maternal socioeconomic status
(SES) (P= .001), paternal age (P= .001), and paternal psychi-
atric history (P < .001). In addition, number of the siblings in
the sibship (P = .006) was added as a covariate into finalLeivonen et al
April 2016 ORIGINAL ARTICLESmodel. In additional analyses, prenatal maternal smoking
(yes/no) (P = .007) was also added as a covariate into final
model. Maternal age was classified as <20, 20-24, 25-34,
35-39, and $40 years. Maternal SES, based on occupation
during pregnancy, was derived from the FMBR and catego-
rized upper white collar, lower white collar, blue collar, or
other. Maternal lifetime psychiatric history, derived from
the FHDR, was defined as a psychiatric diagnosis given in
the specialized healthcare and classified as yes or no. “Yes”
included any mental disorder corresponding to diagnoses
F10-F99, excluding intellectual disability F70-F79 (ICD-
10)1; 291-316; organic psychiatric conditions 293-294 and
310 (ICD-9), and 291-308; organic psychiatric conditions
292-294 (except psychiatric disorder because of intoxication
294.30); and conditions because of sexuality 302 (ICD,
Eighth Revision). Data on maternal smoking, derived from
the FMBR, were categorized as either yes or no. Number of
children in the sibship included the siblings delivered by
the same mother and was classified as 1, 2, 3, and 4 or more.
Data Analyses
Conditional logistic regression analysis was used to examine
the association between neonatal factors, obstetric factors,
parity and Tourette syndrome. The ORs and 95% CIs were
calculated with a statistical significance limit of P < .05. First,
the unadjusted ORs with 95% CIs were calculated separately
for every factor and Tourette syndrome. Second, the associ-
ation between every factor and Tourette syndrome was eval-
uated adjusting for the 5 parental covariates previously
noted. Subsequently, based on the results of the adjusted
models, a final model was created including the risk factors
significantly associated with Tourette syndrome, the 5
parental covariates, number of the siblings in the sibship,
and gestational age. In additional analyses, prenatal maternal
smoking was added as a covariate in the final model. Statis-
tical analyses were performed with SAS statistical software
(v 9.4; SAS Institute Inc, Cary, North Carolina).
Results
Table I shows the frequencies of examined factors among
cases and controls. The unadjusted and adjusted ORs for
the obstetric factors, neonatal factors, parity, and Tourette
syndrome are also shown in Table I. In the adjusted
analyses, statistically significant associations were found
between parity, birth weight, birth type, and Tourette
syndrome, respectively. Nulliparity was associated with
increased odds for Tourette syndrome, and furthermore, 3
or more previous births were associated with decreased
odds for Tourette syndrome compared with 1-2 previous
births. Birth weight 4000-4499 g, compared with 2500-
3999 g, was associated with decreased odds for Tourette
syndrome and birth type (vacuum extractor, forceps, or
vaginal breech) was associated with increased odds for
Tourette syndrome. In the adjusted analyses, no statistically
significant associations were found between gestational age,
weight for gestational age, Apgar at 1 minute, inducedObstetric and Neonatal Adversities, Parity, and Tourette Syndromlabor, neonatal treatment, or maternal blood pressure, and
Tourette syndrome.
Table II shows the final model including parity, birth
weight, and birth type and covariates: maternal age,
maternal psychiatric history, maternal SES, paternal age,
paternal psychiatric history, gestational age, and number of
the siblings in the sibship. Parity 3 or more previous births
and birth weight 4000-4499 g were associated with
decreased odds for Tourette syndrome. Nulliparity
remained to be associated with increased odds for Tourette
syndrome. In the final model, there was no statistically
significant association between birth type and Tourette
syndrome. There were no significant differences in the
results when prenatal maternal smoking was added as a
covariate into final model in the additional analyses.
Discussion
This large nationwide register-based study reports the rela-
tionship between parity, obstetric adversities, neonatal fac-
tors, and Tourette syndrome. Both increasing parity and
high birth weight were significantly associated with decreased
odds for Tourette syndrome. In contrast with previous find-
ings related to other neuropsychiatric disorders, such as ASD
and ADHD, Tourette syndrome was not associated with low
birth weight, prematurity, or other obstetric or neonatal ad-
versities.
Nulliparity was associated with increased odds for Tour-
ette syndrome. In addition, the odds for Tourette syndrome
decreased with increasing parity: parity greater than 2 was
associated with lower odds of Tourette syndrome than parity
of 1 or 2. Nulliparity has been associated with increased risk
for autism,12-14 ADHD,35,36 schizophrenia,37 and other
mental health problems,36,38 although these studies are not
univocal.39-42 The mechanisms underlying the association
between nulliparity and adverse neurodevelopmental out-
comes remain unknown. Given the expected multifactorial
etiology for Tourette syndrome, it seems reasonable to
consider both biological and behavioral mechanisms
whereby the experience of one pregnancy changes fetal expo-
sure and/or parental behavior in the next pregnancy in early
infancy. Previously suggested biological explanations include
the hygiene hypothesis,12,13 and exposure to higher lipophilic
chemicals during the first pregnancy.12,13 The hygiene hy-
pothesis suggests that lack of early infectious disease exposure
leads to an autoimmune susceptibility among first born chil-
dren and increased exposure to infections among the later
born children would rather be protective.43 This mechanism
could be of relevance because abnormal regulation of the im-
mune system could be associated with Tourette syndrome.44
A fetus in an earlier pregnancy is exposed to higher concen-
trations of lipophilic chemicals than a fetus in a later preg-
nancy,45 and some of these chemicals have been associated
with adverse neurodevelopmental outcomes.46 Altered
maternal behavior relative to parity might also lead to
different toxic exposures depending on birth order. For
instance, binge drinking and cannabis use during pregnancye: A Nationwide Registry 215
Table I. The associations between neonatal factors, obstetric factors, parity, and Tourette syndrome
Cases Controls Unadjusted Adjusted model*
n (%) n (%) OR (95% CI) P OR (95% CI) P
Birth weight (g)
<1500 6 (0.8) 16 (0.6) 1.3 (0.5-3.4) .566 1.1 (0.4-3.0) .847
1500-2499 26 (3.5) 68 (2.4) 1.4 (0.8-2.2) .204 1.3 (0.7-2.1) .403
2500-3999 588 (79.7) 2074 (73.8) 1.0 1.0
4000-4499 101 (13.7) 527 (18.8) 0.7 (0.5-0.8) .001 0.7 (0.5-0.9) .002
$4500 17 (2.3) 125 (4.5) 0.5 (0.3-0.8) .005 0.6 (0.3-1.1) .084
Gestational age (wk)
#31 8 (1.1) 14 (0.5) 2.2 (0.9-5.3) .074 1.8 (0.7-4.7) .264
32-37 76 (10.3) 248 (8.8) 1.2 (0.9-1.6) .207 1.2 (0.9-1.6) .312
38-41 624 (84.6) 2421 (86.2) 1.0
$42 30 (4.1) 127 (4.5) 0.9 (0.6-1.4) .684 0.9 (0.6-1.5) .788
Weight for gestational age
SGA 21 (2.9) 80 (2.9) 1.0 (0.6-1.6) .998 1.0 (0.5-1.7) .913
AGA 702 (95.1) 2628 (93.5) 1.0
LGA 15 (2.0) 102 (3.6) 0.5 (0.3-0.96) .034 0.7 (0.4-1.2) .171
Apgar at 1 min
9-10 547 (74.1) 2147 (76.4) 1.0 1.0
7-8 152 (20.6) 561 (20.0) 1.1 (0.9-1.3) .549 1.0 (0.8-1.3) .828
0-6 39 (5.3) 102 (3.6) 1.5 (1.01-2.2) .044 1.5 (0.98-2.3) .062
Induced labor
No 617 (83.6) 2360 (84.0) 1.0 1.0
Yes 121 (16.4) 571 (16.1) 1.0 (0.8-1.3) .747 1.1 (0.9-1.4) .408
Birth type
Vaginal cephalic 547 (74.1) 2173 (77.3) 1.0 1.0
Vacuum extractor/forceps/vaginal breech 63 (8.5) 178 (6.3) 1.4 (1.04-1.9) .028 1.5 (1.1-2.1) .020
Planned cesarean 58 (7.9) 220 (7.8) 1.0 (0.8-1.4) .792 1.0 (0.7-1.4) .982
Emergency/urgent cesarean 70 (9.5) 233 (8.3) 1.2 (0.9-1.6) .204 1.1 (0.8-1.6) .435
Unknown 0 6 (0.2) N/A N/A
Birth presentation
Cephalic 695 (94.2) 2646 (94.2) 1.0 1.0
Breech 23 (3.1) 66 (2.4) 1.3 (0.8-2.2) .236 1.2 (0.7-2.0) .536
Other 20 (2.7) 98 (3.5) 0.8 (0.5-1.3) .294 0.8 (0.4-1.4) .379
Neonatal treatment
Normal 665 (90.1) 2583 (91.9) 1.0 1.0
Monitoring/NICU 73 (9.9) 227 (8.1) 1.3 (0.95-1.7) .104 1.2 (0.9-1.6) .210
Maternal high blood pressure
No 699 (94.7) 2694 (95.9) 1.0
Yes 39 (5.3) 116 (4.1) 1.3 (0.9-1.9) .189 1.2 (0.8-1.8) .384
Parity
0 414 (56.1) 1150 (41.0) 1.7 (1.4-2.0) <.001 1.8 (1.5-2.2) <.001
1-2 296 (40.1) 1406 (50.1) 1.0 1.0
$3 28 (3.8) 248 (8.8) 0.5 (0.3-0.8) .002 0.5 (0.3-0.7) .001
AGA, appropriate for gestational age; LGA, large for gestational age; NICU, neonatal intensive care unit, N/A, not applicable; SGA, small for gestational age.
*Adjusted with maternal age, maternal SES, maternal psychiatric history, paternal age, and paternal psychiatric history.
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Tourette syndrome.24 In addition, changes in maternal hor-
monal environment, including higher testosterone levels in
the first pregnancy, have been associated with parity.49 The
role of neuroendocrine mechanisms and Tourette syndrome
is understudied, though there is a hypothesis, based on indi-
rect measures, that patients with Tourette syndrome are
exposed to higher concentrations of androgens in utero.50
It has been suggested that autism in the child might lead to
reproductive stoppage in the family, leading to reproductive
choice biasing the relationship between parity and autism.51
However, in our study the sibship size was added as a covar-
iate, and Tourette syndrome is also likely to be diagnosed
later than autism.26,52
Birth weight of 4000-4499 g was associated with decreased
odds for Tourette syndrome. In general, the infant’s size is an
indicator of prenatal well-being, and both low and high birth216weights have been associated with adverse long-term conse-
quences such as obesity, metabolic disorders, and neurodeve-
lopmental disorders.53 Therefore, our finding was
unexpected and intriguing. Some explanations associated
with factors affecting birth weight can be hypothesized. Birth
size is mediated by both genetic54 and environmental factors,
such as parity, maternal size, medication, smoking, and
nutrition.55 Thus, our finding raises the question of whether
some of the factors associated with high birth weight (genetic
or maternal size or nutrition), could have protective effects
for Tourette syndrome. Replication of our findings and
further studies examining the possible mechanisms are desir-
able to confirm the results and understand nature of the
found association.
Low birth weight, gestational age, weight for gestational
age, Apgar score at 1 minute, induced labor, birth presenta-
tion or birth type, neonatal treatment, or maternal bloodLeivonen et al
Table II. The final model including the factors associated with Tourette syndrome and covariates
Cases Controls Final model*
n (%) n (%) OR (95%CI) P
Birth weight (g)
<1500 6 (0.8) 16 (0.6) 0.3 (0.02-3.9) .334
1500-2499 26 (3.5) 68 (2.4) 1.1 (0.6-2.0) .774
2500-3999 588 (79.7) 2074 (73.8) 1.0
4000-4499 101 (13.7) 527 (18.8) 0.7 (0.5-0.9) .013
$4500 17 (2.3) 125 (4.5) 0.7 (0.4-1.3) .255
Birth type
Vaginal cephalic 547 (74.1) 2173 (77.3) 1.0
Vacuum extractor/forceps/vaginal breech 63 (8.5) 178 (6.3) 1.1 (0.8-1.6) .443
Planned cesarean 58 (7.9) 220 (7.8) 0.9 (0.6-1.2) .378
Emergency/urgent cesarean 70 (9.5) 233 (8.3) 1.0 (0.7-1.2) .794
Unknown 0 6 (0.2) N/A .977
Parity
0 414 (56.1) 1150 (41.0) 1.7 (1.4-2.2) <.001
1-2 296 (40.1) 1406 (50.1) 1.0
$3 28 (3.8) 248 (8.8) 0.5 (0.3-0.9) .018
*Adjusted with maternal age, maternal SES, maternal psychiatric history, paternal age, paternal psychiatric history, the number of children in the sibship, and gestational age.
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estingly, associations between low birth weight and ADHD
and autism, respectively, have been shown in several
studies.6-8 Furthermore, small for gestational age, low Apgar
score, and prematurity have also been associated with both
disorders and abnormal presentation, maternal high blood
pressure, and neonatal treatment have been associated
with autism.6-9,11 As the examined factors can be considered
as possible markers of several prenatal risk factors including
intrauterine growth restriction, fetal distress, placental pa-
thology, and pre-eclampsia, our results suggest that these
adversities that may be involved in the etiology of ADHD
or ASD, are not associated with Tourette syndrome. Howev-
er, although this is the largest study of prospectively
collected prenatal/perinatal risk factors for Tourette syn-
drome, the sample size is still somewhat small compared
with sample sizes in prenatal epidemiologic studies about
ADHD and ASD.6-9 Therefore, the absence of the associa-
tions between some of the obstetric and neonatal factors
and Tourette syndrome could potentially be due to lack of
power.
The register-based design provides strengths such as pro-
spectively collected data, a large, nationwide sample, data
on several potential confounding factors, and validated diag-
noses. However, not all children in Finland with Tourette
syndrome are diagnosed and treated by specialist services26
and, therefore, cannot be found in the FHDR. Nevertheless,
virtually all children in Finland attend regular health screens
at child health and school clinics. Thus, it is likely that the
most severe cases of Tourette syndrome are recognized,
referred to specialized health clinics, and registered. Another
limitation is that although several maternal confounding fac-
tors could be controlled in the study, there are factors such as
maternal nutrition and drinking behavior that are not avail-
able in the registers. Furthermore, Apgar score at 5 minutes
would have been a better indicator of long-term outcomes
in child than Apgar at 1 minute.56 However, Apgar score at
5 minutes was not recorded in the FMBR during the wholeObstetric and Neonatal Adversities, Parity, and Tourette Syndromstudy period. It was available only for 1% of the sample,
and thus, it could not be chosen. In addition, the examined
exposures, particularly the lowest birth weight and gesta-
tional age, were relatively rare. Thus, stratifying the cases
based on common comorbidities including ADHD, ASD,
and obsessive compulsive disorder would have required
even larger sample size. No corrections of the P values were
conducted for multiple comparisons; this can be accounted
for while interpreting the results. However, correcting P
values has not been a standardmethod in studies using epide-
miologic categorized data and conditional logistic regression
analyses.7-9,12,13,33,34,41
In conclusion, previously unrecognized factors as high
birth weight and 3 or more previous births were associated
with decreased odds for Tourette syndrome. In addition to
examining the risk factors, identification of protective factors
for Tourette syndrome may lead to better understanding of
the etiology of the disorder. Further examination of the fac-
tors associated with prenatal growth or parity (eg, prenatal
maternal nutrition, maternal hormonal levels during preg-
nancy, exposure to infections, or genetic factors) and their
relationship with Tourette syndrome could help to clarify
the nature of the detected associations. n
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Japan. Pediatr Int 2014;56:215-21.Charts of Normal Body Measurement and Revised Width-Weight Tables in
Graphic Form
Pryor H. J Pediatr 1966;68:615-31
In 1966, Helen Pryor described the use of charts to aid parental understanding of their child’s growth. AlthoughPryor used some variables and terms that are no longer used to define childhood growth (eg, “big boned” vs “small
boned”), the challenge she described exists to this day. Parents get easily confused by the terminology we readily use as
medical providers. In the study by Pryor, using charts and sharing a graphical description of growth points was found
to improve parental understanding of childhood growth.
Numerous studies show that parents do not recognize when their children are above ideal body weight. Several chal-
lenges exist with using body mass index percentile (BMI%) even though it is the standard for discussing weight status
with parents. Body composition, unexpected effects of greater height, and BMI rebound at age 4- to 6 years can make
BMI% interpretation confusing for healthcare providers and parents. In an era when higher percentiles identify aca-
demic and athletic prowess, high BMI%may sound desirable to parents. Additionally, medical providers use BMI% to
define the terms obese and overweight, but these terms have the potential to be off-putting or offensive to
parents when not put into a clear medical context. Color-coded BMI charts to identify children in green (BMI%
5%-85%), yellow (BMI% 85%-95%), and red (BMI% >95%) zones have been shown as one way to enhance parent
understanding of weight status.1 Other strategies are also being employed or are under development.
Whether BMI% remains the vernacular for discussing childhood weight status or whether it goes the way of “big
boned” remains to be seen. Regardless, if we are to engage parents and other caregivers to meet the challenge of this
nation’s pediatric obesity crisis, it is necessary for medical providers to use terminology and techniques that empower
them and avoid those that stigmatize or confuse them.
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